ADC Common Stock Shares Outstanding from 2010 to 2025
| ADCT Stock | USD 4.61 0.18 4.06% |
Common Stock Shares Outstanding | First Reported 2018-03-31 | Previous Quarter 107.2 M | Current Value 113.7 M | Quarterly Volatility 16.4 M |
Check ADC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ADC Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 174.3 K, Interest Income of 12.9 M or Depreciation And Amortization of 2.2 M, as well as many indicators such as Price To Sales Ratio of 2.59, Dividend Yield of 0.0 or Days Sales Outstanding of 99.45. ADC financial statements analysis is a perfect complement when working with ADC Therapeutics Valuation or Volatility modules.
ADC | Common Stock Shares Outstanding | Build AI portfolio with ADC Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.